Figures & data
Figure 2 Scanning electron micrographs of unprocessed ARTM (A); transmission electron micrographs of ARTM nanocrystals (B); impact of milling time on particle size reduction (C); and Zeta potential values of different ARTM nanocrystals (D).
![Figure 2 Scanning electron micrographs of unprocessed ARTM (A); transmission electron micrographs of ARTM nanocrystals (B); impact of milling time on particle size reduction (C); and Zeta potential values of different ARTM nanocrystals (D).](/cms/asset/9885ae45-46bf-4ef0-b512-369cdf47b307/dddt_a_12173074_f0002_b.jpg)
Table 1 Effect of various ARTM concentrations (2.5% and 10%) in water and at pH 2.0 on the mean particle sizes (nm) of ARTM nanocrystals in nanosuspension
Table 2 Effect of various ARTM concentrations (2.5% and 10%) in water and at pH 2.0 on active contents of ARTM nanocrystals
Figure 3 Physical stability of ARTM nanocrystals in terms of monitoring the particle size and PDI at various time points on storage at (A) 2°C–8°C, (B) 25°C, and (C) 40°C.
![Figure 3 Physical stability of ARTM nanocrystals in terms of monitoring the particle size and PDI at various time points on storage at (A) 2°C–8°C, (B) 25°C, and (C) 40°C.](/cms/asset/99db12de-2dd6-4a87-84dc-d89480fa6c28/dddt_a_12173074_f0003_b.jpg)
Figure 4 DSC thermogram of milled and unprocessed ARTM (A) and PXRD patterns of unprocessed and milled ARTM (B).
![Figure 4 DSC thermogram of milled and unprocessed ARTM (A) and PXRD patterns of unprocessed and milled ARTM (B).](/cms/asset/e6c684d3-61c5-4423-9d84-a2163d697ae4/dddt_a_12173074_f0004_c.jpg)
Figure 5 Solubility studies of ARTM nanocrystals, unprocessed ARTM in pure water, and stabilizer solution.
![Figure 5 Solubility studies of ARTM nanocrystals, unprocessed ARTM in pure water, and stabilizer solution.](/cms/asset/870105be-0ad8-4d71-8d98-4dec7d49607f/dddt_a_12173074_f0005_b.jpg)
Figure 6 Comparative dissolution profile of ARTM nanocrystals, microsuspension, micronized drug, marketed tablets, and raw ARTM.
![Figure 6 Comparative dissolution profile of ARTM nanocrystals, microsuspension, micronized drug, marketed tablets, and raw ARTM.](/cms/asset/a680d0ec-9489-4f8f-99ae-69bf56f1a156/dddt_a_12173074_f0006_b.jpg)
Figure 7 Monitoring of percent parasitemia (A) and antimalarial activities (B) in different groups of mice using ARTM nanocrystals, microsuspension, marketed formulation, and unprocessed ARTM.
![Figure 7 Monitoring of percent parasitemia (A) and antimalarial activities (B) in different groups of mice using ARTM nanocrystals, microsuspension, marketed formulation, and unprocessed ARTM.](/cms/asset/1508396b-8ddd-4725-b39f-d1f47aa3b64d/dddt_a_12173074_f0007_b.jpg)
Table 3 Number of Swiss albino mice to survive between the different groups at 2 mg/kg (ARTM)